You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
林郑:辉瑞-BioNTech疫苗抵港後可立即使用 冀尽快获科兴数据
阿思达克 02-02 10:09
行政长官林郑月娥表示,希望尽快获得内地生产疫苗的数据,并交由本港专家委员会审批後,推荐食物及卫生局长作紧急使用。而此前向中央寻求支持,亦无特别指明哪一款疫苗。

她指,辉瑞-BioNTech之疫苗,在抵港後,相信可立即开始使用。至於另一只牛津大学与英国药厂阿斯利康(AZN.US)的疫苗,原订时间亦是於下半年才供港。

她又指,至今采取8次封区强制检测行动不是「劳民伤财」,相反是非常值得,有效性明显,行动是由食物及卫生局局长按《预防及控制疾病条例》列明决定封锁范围,形容有关决定是科学判断,每日就哪个地区作出宣告。

另外,就有关於早前以视像述职的安排属於中央决定,行政长官需要全面配合,由於北京近期仍有零散疫情个案,因此述职工作改以视频进行,并在完成後由新华社、央视及本港政府新闻处公布。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account